Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02JZJ
|
|||
| Former ID |
DIB009440
|
|||
| Drug Name |
ETS-6218
|
|||
| Synonyms |
Antihistamine+antiviral (fibromyalgia), e-Therapeutics
Click to Show/Hide
|
|||
| Indication | Fibromyalgia [ICD-11: MG30.01; ICD-10: M79.7; ICD-9: 729.1] | Phase 2 | [1] | |
| Company |
E-Therapeutics Ltd
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine receptor (HR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031879) | |||
| REF 2 | Clinical pipeline report, company report or official report of e-Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.